Maintaining exercise when the cardiac rehab is complete

The Miriam Hospital study finds telephone intervention helps keep patients on track

 

Providence, Rhode Island, USA (August 23, 2011) – Researchers from The Miriam Hospital have found that patients who have completed cardiac rehabilitation and who receive telephone counseling that supports exercise are more likely to adhere to an exercise program. Results of the study, funded by the National Heart, Lung and Blood Institute, are published in the American Journal of Preventive Medicine.

 

Traditionally, patients who complete Phase II cardiac rehabilitation often have low rates of maintaining exercise after program completion. If patients who have completed cardiac rehabilitation do not maintain regular exercise, they are at risk for repeated cardiac events and hospitalizations. Lifestyle changes such as staying regularly active, along with prescribed medications, are important for preventing future hospitalizations in this high risk population.

 

With that in mind, researchers at The Miriam Hospital developed a randomized controlled trial to determine the efficacy of a home-based intervention to support exercise maintenance. Patients who completed cardiac rehabilitation were randomly chosen to receive phone interventions with exercise counseling (maintenance counseling group) or to receive only telephone support (contact control group) that did not focus on exercise. Data was collected over a period of five years and included 130 patients.

 

Bernardine Pinto, Ph.D., a researcher at The Miriam Hospital and a professor at The Warren Alpert Medical School of Brown University, led the study. She reports that when the data was analyzed, they found that the maintenance counseling group reported they were exercising at or above the weekly recommendations, were more motivated to stay active, and had better physical functioning than the control group at 12 months. There was a significant drop in weekly exercise in the control group over time. The researchers found that at six months, the counseling group’s weekly exercise was approximately 32 minutes more than that of the control group. By 12 months, patients in the counseling group reported an average difference of 80 minutes of exercise per week compared to those in the control group.

 

Pinto explains that both groups received the same number of support calls; however, the patients in the control group did not receive focused exercise phone support. She adds, "It was also very encouraging to find that even patients with lower levels of exercise at the time of cardiac rehab discharge were particularly helped by the telephone counseling.

 

The researchers are greatly encouraged by the positive findings of the study. Pinto says, "While patients benefit from taking part in cardiac rehabilitation programs, six months after discharge, only 30 to 60 percent of patients report regular exercise. Our study shows that specific support for exercise is important if we want cardiac patients to stay active over the long-term and can easily be delivered through a telephone-based intervention. In the absence of such support, gains in exercise that patients have achieved while participating in cardiac rehabilitation may be lost with time."

The Miriam Hospital (www.miriamhospital.org) is a 247-bed, not-for-profit teaching hospital affiliated with The Warren Alpert Medical School of Brown University. It offers expertise in cardiology, oncology, orthopedics, men’s health, and minimally invasive surgery and is home to the state’s first Joint Commission-certified Stroke Center and robotic surgery program. The hospital is nationally known for its HIV/AIDS and behavioral and preventive medicine research, including weight control, physical activity and smoking cessation. The Miriam Hospital has been awarded Magnet Recognition for Excellence in Nursing Services four times and is a founding member of the Lifespan health system.

 

 


The Miriam Hospital, Providence, Rhode Island, USA, 23.08.2011 Nursing News (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…